OncLive® On Air

Hodgkin's Lymphoma

Chemotherapy

Oncology

Colorectal Cancer

Nivolumab

Onc201

Hepatic Artery Infusion

H3K27M Mutant Diffuse Midline Gliomas

Immunotherapy

CAR T-Cell Therapy

ACTION Trial

Her2-Positive Breast Cancer

Ponatinib

FDA Approval

SWOG 1826

Siltocaptagine Autolucel

Multiple Myeloma

Colorectal Cancer Management

Malignant Perivascular Epithelioid Cell Tumors

Glioma

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers,... more

30 ratings

Publishes	Daily	Episodes	500	Founded	7 years ago
Number of Listeners		Categories	ScienceHealth & Fitness

Listen to this Podcast

Guests Reviews Talking Points

Latest Episodes

S14 Ep54: Advances in Breast Cancer ADCs and Endocrine Therapy Take Center Stage at CFS: With Benjamin P. Levy, MD; Kamel Abou Hussein, MD; and Victoria Rizk, MD

In today’s episode,filmed live at the 43rd Annual CFS Chemotherapy Foundation Symposium, lung cancer expert Benjamin P. Levy, MD, hosted a cross-specialty discussion with breast cancer experts Kamel Abou Hussein, MD, and Victoria Rizk, MD, about the ... more

24 Nov 2025 • 16 min

S14 Ep53: Teclistamab-Based Induction Is Effective and Generates MRD Negativity in Newly Diagnosed Myeloma: With Marc S. Raab, MD

In today’s episode, we had the pleasure of speaking with Marc S. Raab, MD, about the post-induction outcomes and updated minimal residual disease (MRD) analyses from the phase 2 MajesTEC-5 study (NCT05695508), which is evaluating teclistamab-cqyv (Te... more

24 Nov 2025 • 7 min

S14 Ep52: FDA Approval Insights: Ziftomenib in NPM1+ R/R AML: With Harry P. Erba, MD, PhD

Welcome to OncLive On Air®!

OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every ang... more

21 Nov 2025 • 20 min

S14 Ep51: Insights and Implications of AI’s Expanding Role in Hematologic Malignancy Care: With Justin Taylor, MD

In today’s episode, we had the pleasure of speaking with Justin Taylor, MD, an associate professor in the Division of Hematology at the University of Miami Miller School of Medicine, about the growing role of artificial intelligence in cancer informa... more

19 Nov 2025 • 14 min

Key Facts

Accepts Guests

Accepts Sponsors

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc DocsSam and Karine

Oncology Brothers: Practice-Changing Cancer DiscussionsOncology Brothers

Oncology Today with Dr Neil LoveDr. Neil Love

Research To Practice | Oncology VideosDr Neil Love

ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

Recent Guests

Justin Taylor, MD

Associate professor in the Division of Hematology at the University of Miami Miller School of Medicine

University of Miami Miller School of Medicine

Episode: S14 Ep51: Insights and Implications of AI’s Expanding Role in Hematologic Malignancy Care: With Justin Taylor, MD

Hira Mian

MD, MSc, FRCPC specializing in oncology

Episode: S14 Ep42: Dynamic Frailty Assessment Underscores Need for Ongoing Evaluation in Transplant-Ineligible Multiple Myeloma: With Hira Mian, MD, MSc, FRCPC

Amit Mehta, MD

Oncologist specializing in urothelial carcinoma treatment

Episode: S14 Ep36: Evolving Research Paradigms, Real-World Data, and Multidisciplinary Collaboration Enhance Bladder Cancer Management: With Amit Mehta, MD

Eunice Wang, MD

An expert in the treatment of secondary AML

Episode: S14 Ep32: Evolving Treatment Strategies and Novel Therapies Reshape Secondary AML Management: With Eunice Wang, MD

J. Thaddeus Beck, MD, FACP

Discussion expert on FDA approval of subcutaneous pembrolizumab

Episode: S14 Ep30: FDA Approval Insights: Subcutaneous Pembrolizumab for Solid Tumors: With J. Thaddeus Beck, MD, FACP

Joseph Jacob

Director of Urologic Oncology at Upstate Medical University and global primary investigator of the Sunrise 1 trial

Upstate Medical University

Episode: S14 Ep27: FDA Approval Insights: Gemcitabine Intravesical System for NMIBC: With Joseph Jacob, MD, MCR

Lyudmila Bazhenova, MD

An expert in oncology discussing FDA approval of Sun Vazirtenib.

Episode: S14 Ep26: FDA Approval Insights: Sunvozertinib in EGFR-Mutated Metastatic NSCLC: With Lyudmila Bazhenova, MD

Stephen Liu

Oncologist specializing in lung cancer and targeted therapies

Not specified in the episode

Episode: S14 Ep23: Early Biomarker Testing Optimizes Tepotinib Use in NSCLC With MET Exon 14 Skipping Mutations: With Stephen Liu, MD

Andrew Kuykendall, MD

A physician expert discussing myelofibrosis treatment

Episode: S14 Ep22: Expanding JAK Inhibitor Use Offers Increased Treatment Options for Cytopenic Myelofibrosis: With Andrew Kuykendall, MD

Reviews

4.5 out of 5 stars from 30 ratings

Best option for CME podcasts
Love the content! Easily the best platform for listening to CME and staying updated while on the go. Keep up the great work!
Apple Podcasts
5
Dlshaka
United States5 months ago
My favorite podcast for oncology
This podcast provides excellent information to anyone who works in the medical field on oncology.
Apple Podcasts
5
Chiliman1986
United States6 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Many appreciate the detailed discussions surrounding the latest research and advancements in cancer treatment.

Listeners praise the insightful content and expert interviews provided, citing it as an excellent resource for oncology professionals.

Top Health & Fitness Podcasts

Passion Struck with John R. MilesPassion Struck Network

We're Out of TimeRichard Taite

The Dylan Gemelli PodcastDylan Gemelli

Huberman LabScicomm Media

The NightlyHatch Podcasts

The Peter Attia DrivePeter Attia, MD

On Purpose with Jay ShettyiHeartPodcasts

unPAUSED with Dr. Mary Claire HaverAudacy | Mary Claire Haver, MD

Nothing much happens: bedtime stories to help you sleepWellness Loud

The Dr. John Delony ShowRamsey Network

Talking Points

Recent interactions between the hosts and their guests.

S14 Ep43: ARROS-1 Data Show Zidesamtinib's Favorable Safety Profile, Spark Discussion to Clarify Its Role in ROS1+ NSCLC: With Stephen Liu, MD

Q: In terms of safety, what has the profile of this agent look like so far?

Zidesamtinib has demonstrated less track related toxicity, with the only significant treatment-related adverse event being edema and low rates of serious toxicities, indicating a favorable safety profile.

S14 Ep43: ARROS-1 Data Show Zidesamtinib's Favorable Safety Profile, Spark Discussion to Clarify Its Role in ROS1+ NSCLC: With Stephen Liu, MD

Q: Could you provide just a quick overview of the EROS-1 trial, specifically just what types of patients were enrolled here?

The EROS-1 trial is a multi-cohort study looking at Zidesamtinib and was designed to explore efficacy in different cohorts, particularly those with ROS-1 fusions while excluding tumors with Ntrec fusions.

S14 Ep27: FDA Approval Insights: Gemcitabine Intravesical System for NMIBC: With Joseph Jacob, MD, MCR

Q: What is the safety profile that was seen with TAR-200?

The drug is considered safe with most adverse events being urinary in nature, indicating low treatment discontinuations and no reported deaths.

S14 Ep27: FDA Approval Insights: Gemcitabine Intravesical System for NMIBC: With Joseph Jacob, MD, MCR

Q: What is the significance of this approval and how does it address an unmet need for this patient population?

The approval signifies a new effective treatment option for patients who previously had limited options, specifically benefiting those with BCG-unresponsive non-muscle invasive bladder cancer.

S14 Ep23: Early Biomarker Testing Optimizes Tepotinib Use in NSCLC With MET Exon 14 Skipping Mutations: With Stephen Liu, MD

Q: What safety considerations are important to remember when using Tepotinib?

Liu discusses the toxicity profile of Tepotinib, particularly the common occurrence of peripheral edema and emphasizes the importance of monitoring and managing this side effect.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncLive® On Air

What is OncLive® On Air about and what kind of topics does it cover?

The podcast offers insightful interviews with academic oncologists, focusing on the latest advancements and thought-provoking presentations in the field of oncology. With episodes spanning a wide array of topics including systemic therapies, surgery, and radiation therapy, the discussions cover various cancers like breast, lung, gastrointestinal, hematologic, gynecologic, and genitourinary. Notably, the show highlights emerging therapeutic approaches and ongoing research, creating a valuable resource for healthcare professionals seeking to stay updated on the evolving landscape of cancer treatment.

Where can I find podcast stats for OncLive® On Air?

Rephonic provides a wide range of podcast stats for OncLive® On Air. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncLive® On Air and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncLive® On Air get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for OncLive® On Air, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncLive® On Air?

Rephonic provides comprehensive predictive audience data for OncLive® On Air, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncLive® On Air have?

To see how many followers or subscribers OncLive® On Air has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to OncLive® On Air?

These podcasts share a similar audience with OncLive® On Air:

1. Two Onc Docs
2. Oncology Brothers: Practice-Changing Cancer Discussions
3. Oncology Today with Dr Neil Love
4. Research To Practice | Oncology Videos
5. ASCO Daily News

How many episodes of OncLive® On Air are there?

OncLive® On Air launched 7 years ago and published 500 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncLive® On Air?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncLive® On Air?

Rephonic pulls ratings and reviews for OncLive® On Air from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncLive® On Air?

Rephonic provides full transcripts for episodes of OncLive® On Air. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncLive® On Air?

Recent guests on OncLive® On Air include:

1. Justin Taylor, MD
2. Hira Mian
3. Amit Mehta, MD
4. Eunice Wang, MD
5. J. Thaddeus Beck, MD, FACP
6. Joseph Jacob
7. Lyudmila Bazhenova, MD
8. Stephen Liu

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days